Erythropoietin: a candidate treatment for mood symptoms and memory dysfunction in depression
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Erythropoietin : a candidate treatment for mood symptoms and memory dysfunction in depression. / Miskowiak, Kamilla W; Vinberg, Maj; Harmer, Catherine J; Ehrenreich, Hannelore; Kessing, Lars V.
In: Psychopharmacology, Vol. 219, No. 3, 2012, p. 687-98.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Erythropoietin
T2 - a candidate treatment for mood symptoms and memory dysfunction in depression
AU - Miskowiak, Kamilla W
AU - Vinberg, Maj
AU - Harmer, Catherine J
AU - Ehrenreich, Hannelore
AU - Kessing, Lars V
PY - 2012
Y1 - 2012
N2 - Current pharmacological treatments for depression have a significant treatment-onset-response delay, an insufficient efficacy for many patients and fail to reverse cognitive dysfunction. Erythropoietin (EPO) has neuroprotective and neurotrophic actions and improves cognitive function in animal models of acute and chronic neurodegenerative conditions and in patients with cognitive decline.
AB - Current pharmacological treatments for depression have a significant treatment-onset-response delay, an insufficient efficacy for many patients and fail to reverse cognitive dysfunction. Erythropoietin (EPO) has neuroprotective and neurotrophic actions and improves cognitive function in animal models of acute and chronic neurodegenerative conditions and in patients with cognitive decline.
U2 - 10.1007/s00213-011-2511-1
DO - 10.1007/s00213-011-2511-1
M3 - Journal article
C2 - 21947319
VL - 219
SP - 687
EP - 698
JO - Psychopharmacology
JF - Psychopharmacology
SN - 0033-3158
IS - 3
ER -
ID: 48496536